Texas Urology Specialists-Texas Center for Proton Therapy

Dr. Ashley Ross, with Texas Urology Specialists, leverages the advanced imaging capabilities of Texas Center for Proton Therapy to provide patients leading edge screening and diagnostic services, including fusion guided prostate biopsy.

Performed at Texas Center for Proton Therapy in Irving, a fusion guided prostate biopsy utilizes pre-biopsy MRI images of the prostate that are digitally fused to real-time ultrasound during an ultrasound-guided biopsy. Patients first undergo a high quality multi-parametric MRI of the prostate. Texas Center for Proton Therapy’s 3 Tesla MRI has twice the strength of the clinical-setting standard, providing extremely clear images. Experienced radiologists, with the assistance of specialized software, identify and mark the location of suspicious lesions in 3-D. When patients present for their biopsy, the images from the MRI are fused in real-time with images from the ultrasound.

The simultaneous combination of images guides the physician with greater accuracy and provides a clearer view of the biopsy needle. This enhanced view enables physicians to better differentiate between suspicious cells and healthy prostate tissue. Also, physicians can review images in 2-D and 3-D following the biopsy.

Our Urologists

Our urologists and healthcare team members have years of extensive experience in treating urologic conditions, and you are our sole focus. We treat the whole person, not just the disease, and work as a team to customize treatments for your specific condition, including support services to help you meet the personal challenges you may face as a result of your illness.

Latest News

FDA Reviewed Treatment for Aggressive Prostate Cancer
June 27, 2018 - The FDA is reviewing approval of enzalutamide, a drug which lowered the risk of metastasis or death in men with non-metastatic hormone-resistant prostate cancer, according to a new study of 1,400 patients. Dr. Ashley Ross, medical oncologist at Texas Urology Specialists–Plano, discusses the trial.
Prostate Cancer Study: Multi-parametric MRI Improves Risk Assessment and Biopsy Accuracy
March 26, 2018 - Drs. Andrew Lee and Ashley Ross discuss challenges in diagnosing prostate cancer and review recent studies that explore care options.